Tuberous Sclerosis News

  • Everolimus granted European Licence for renal AML

    Everolimus granted European Licence for renal AML Everolimus (trade name Votubia®) has been approved by the regulators for use in the European Union for the treatment of angiomyolipomata (..

  • Christmas Quiz

    Why not get together with family and friends and try our fun Christmas Quiz? You can download it here (http://www.tuberous-sclerosis.org/documents/2012_christmas_quiz.pdf)and ask for a suggested mini..

  • Challenging behaviour: a guide for family carers on getting the right support

    The Challenging Behaviour Foundation has produced three new ‘At a glance’ guides aimed at family carers supporting people whose behaviour is described as challenging. There are sep..

  • Challenging Behaviour information

    The Challenging Behaviour Foundation has produced new summary information sheets about challenging behaviour. Their information sheets are written by experts and cover a wide range of topics conn..